Home

Search results

Silica drug delivery matrix(Page)
Silica - The Natural Solution for Drug Delivery DelSiTech has developed a unique proprietary drug delivery technology based on biodegradable s...

Publications(Page)
Selected publications The silica-based drug delivery technology and its scientific basis has been validated in numerous scientific studies sin...

Patents(Page)
y patents. Currently, the silica technology is covered by ten patent families world-wide up to year 2033. DelSiTech's patents protect the sili...

Benefits(Page)
Best controllability The silica-based drug delivery technology has multiple competitive advantages over other alternative delivery technologi...

Technology(Page)
r drug delivery DelSiTech™Silica is an advanced delivery technology for parenteral and local administration of injectable depot and implant do...

DelSiTech’s Silica Matrix for Ocular Delivery featured in ONdrugDelivery(News)
e area.  DelSiTech’s Silica Matrix platform was chosen to feature in this edition as delivery to the eye is an important and growing part...

DelSiTech Ltd announces positive patent news(News)
filing of a new patent on silica composite formulations strenghtens the Company's leading IPR position is silica based drug delivery technolog...

DelSiTech CEO Lasse Leino interviewed for the benefits of silica based drug delivery on PharmaTelevison(News)
ehind their biodegradable silica-based small molecule drugs, biopharmaceuticals and viral vectors. The interview can be found here:  ...

Virus vector delivery(Page)
for longer time periods. Silica encapsulation offers also other unforeseen benefits to virus-based therapeutic products. DelSiTech is the tec...

Delivery solutions for biological macromolecus(Page)
olecules With DelSiTech's silica matrix you can administer peptides, proteins, RNA, DNA and complex carbohydrates in a controlled fashion. Del...

Technology applications(Page)
plications With DelSiTech™Silica it is possible to administer parenteral controlled release drugs more precisely, safely and cost-effectively ...

Services(Page)
study to demonstrate that silica drug delivery technology is compatible with your active molecule or activecomponent (e.g. viral vector). This...

DelSiTech and Bayer Partner to Develop Innovative Drug Delivery Technology for Ophthalmology(News)
pplication of DelSiTech’s Silica Matrix drug delivery platform to a number of Bayer’s compounds in ophthalmology. “This partnershi...

Supergeneric drug developmet(Page)
otected by the IPR on the silica technology, preventing any competition with the same technology basis. Additional patent protection is sought...

Business Strategy(Page)
license its biodegradable silica based drug delivery technology to biotech and pharma industry customers by providing service for fee, 2) Deve...

Small molecule drug delivery(Page)
ug delivery Biodegradable silica-based technology offers multiple options for small molecule drug delivery needs. We can tailor made the best ...

DelSiTech and MedImmune Presented Poster on Antibody Drug Delivery at AAPS Meeting(News)
er/70131" target="_blank">Silica Microparticles for Sustained Delivery of MR1 Antibody”.   DelSiTech’s biodegradable silica base...

Company Profile(Page)
ogy is based on amorphous silica (SiO2) matrix and sol-gel encapsulation technique which have significant competitive advantages over other te...

Management(Page)
0 years R&D experience in silica-based biomaterials. Dr. Jokinen holds a Doctor of Science in Technology and has a position as Adjunct Profess...

Why work with us(Page)
e. With the  DelSiTech TM Silica Matrix you can: Create novel product opportunites Extend and manage life-cycle of existing products Different...

Pipeline(Page)
products by combining its silica-based drug delivery technology platform with known active substances to produce supergeneric products with su...

European Patent approval for new injectable drug delivery technology(News)
ortfolio in the field of silica based drug delivery technology. The continuously growing portfolio will help our customers to protect even b...

DelSiTech Ltd announces new website launch(News)
proprietary biodegradable silica-based drug delivery technology, announced today the launch of its fully redesigned website...

DelSiTech Ltd files a new patent application in February 2007(News)
ntly the applicability of silica in encapsulation and delivery of biologically active agents.  ...

DelSiTech Ltd starts new collaboration projects with two Animal Health companies(News)
l Health companies in our silica-based drug delivery technology”, said Lasse Leino, CEO of DelSiTech Ltd.“Controlled release drug products are...

DelSiTech Ltd enters licensing agreement with Solani Therapeutics Ltd in animal health(News)
DelSiTech’s biodegradable silica based technology best for our purposes”  DelSiTech’s CEO Dr. Lasse Leino said ”We are natura...

DelSiTech Ltd publishes an animated video on its drug delivery technology(News)
an animated video on its silica based drug delivery platform. The video which lasts less than 4 minutes includes also interviews of Dr...

DelSiTech receives EU funding from Horizon 2020 programme(News)
cognition for DelSiTech’s silica-based drug delivery technology and its potential in various therapeutic applications.”...

DelSiTech features in the April 2016 edition of Pharma Technology Focus Magazine(News)
y features of DelSiTech’s Silica Matrix technology can also be found in the current edition of the magazine.   Pharma Technol...

DelSiTech now also in social media - the Company Facebook pages launched(News)
p explain how DelSiTech’s Silica Matrix Platform works, the benefits associated and the unlimited applications. The link can be found here:...

DelSiTech Featured in a Recent Ocular Drug Delivery Business Report(News)
platforms like DelSiTech Silica technology which provides many benefits such as sustained release, accurate dosing, and ease of administratio...

Home(Page)
ecialist in biodegradable silica-based controlled release of small molecule drugs, biopharmaceuticals and viral vectors. We focus on parentera...